Peter Button
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Hepatitis C virus research 4
-
- Hepatitis B Virus Studies 6
- Co-authors
- Teerha Piratvisuth (5 shared papers)George K.K. Lau (3 shared papers)Young Jae Mok (1 shared paper)Jiafu Ji (1 shared paper)Yong Ho Kim (1 shared paper)Ta-Sen Yeh (1 shared paper)Florin Sirzén (1 shared paper)Hyun Cheol Chung (1 shared paper)
In The Last Decade
Peter Button
27 papers receiving 3.1k citations
Peter Button's Hit Papers
Peers
Comparison fields: 5 of 99
- Hepatology 848
- Gastroenterology 275
- Pulmonary and Respiratory Medicine 1.3k
- Epidemiology 1.2k
- Oncology 486
Countries citing papers authored by Peter Button
This map shows the geographic impact of Peter Button's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Button with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Button more than expected).
Fields of papers citing papers by Peter Button
This network shows the impact of papers produced by Peter Button. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Button. The network helps show where Peter Button may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Button, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Hit paper breakdown → | 2012 | 1398 |
| 2 | Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B Hit paper breakdown → | 2004 | 923 |
| 3 | 2008 | 198 | |
| 4 | 2015 | 192 | |
| 5 | 2009 | 101 | |
| 6 | 2008 | 67 | |
| 7 | 2012 | 66 | |
| 8 | 2015 | 47 | |
| 9 | 2018 | 39 | |
| 10 | 2014 | 33 | |
| 11 | 2021 | 31 | |
| 12 | 2012 | 29 | |
| 13 | 2017 | 25 | |
| 14 | 2014 | 14 | |
| 15 | 2019 | 13 | |
| 16 | 2022 | 12 | |
| 17 | 1997 | 9 | |
| 18 | 2019 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2008 | 5 |
About Peter Button
Peter Button is a scholar working on Hepatology, Epidemiology, Rheumatology, Oncology and Cancer Research, having authored 29 papers that have together received 3.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Hepatitis C virus research (4 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Breast Cancer Treatment Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Hepatology (848 citations), Gastroenterology (275 citations), Pulmonary and Respiratory Medicine (1.3k citations), Epidemiology (1.2k citations) and Oncology (486 citations). Peter Button has collaborated with scholars based in Australia, China and Thailand. Frequent co-authors include Teerha Piratvisuth, George K.K. Lau, Young Jae Mok, Jiafu Ji, Yong Ho Kim, Ta-Sen Yeh, Florin Sirzén, Hyun Cheol Chung, Sung Hoon Noh and Y. Choi. Their work appears in journals such as Journal of Hepatology, Annals of Oncology, Hepatology International, The Lancet and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.